AFAM Capital’s Novartis NVS Stock Holding History

AFAM Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-92,519	Closed	-$7.68M	–	158
2014 Q4	$7.68M	Sell	92,519 -1,601	-2%	-$133K	0.98%	28
2014 Q3	$7.94M	Buy	94,120 +442	+0.5%	+$35.8K	1.01%	23
2014 Q2	$7.6M	Sell	93,678 -1,376	-1%	-$108K	0.95%	30
2014 Q1	$7.24M	Buy	95,054 +645	+0.7%	+$47K	0.97%	27
2013 Q4	$6.8M	Buy	94,409 +1,153	+1%	+$80.1K	0.92%	34
2013 Q3	$6.41M	Buy	93,256 +114	+0.1%	+$7.54K	0.88%	35
2013 Q2	$5.9M	Buy	+93,142	New	+$6.06M	0.82%	40

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AFAM Capital's NVS Position: Q1 2015 in Review

AFAM Capital sold out of Novartis (NVS) in Q1 2015, closing a stake of 92,519 shares — an estimated $7.68M sold.

AFAM Capital first reported a position in NVS in Q2 2013 and held it in 7 quarters. The position peaked at $7.94M in Q3 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

AFAM Capital reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
AFAM Capital sold 92,519 Novartis shares in Q1 2015, an estimated $7.68M.
AFAM Capital first reported a position in Novartis in Q2 2013 and held it in 7 quarters.
AFAM Capital's Novartis position peaked at $7.94M in Q3 2014.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on AFAM Capital's 13F filing for Q1 2015, filed 12 May 2015.